Technology Commercialization Office

Showing 25 result(s) for "Therapeutics"



Small molecules for targeted treatment of triple negative breast cancer and other aggressive phenotypes.

The implantation of engineered thermogenic cells for treating metabolic disease

Identification and use of novel adipokines for reduction of visceral fat using thermogenesis.

An improved delivery mechanism has been developed for camptothecin derivatives which will increase chemotherapeutic efficacy.

A group of potential antitumor arylnapthalene lignan glycosides, which may be developed as novel cancer chemotherapeutic agents.

An efficient delivery vehicle for therapeutic oligonucleotides with high efficiency.

Novel non-peptidomimetic molecules for use as anti-cancer inhibitors of signal transducer and activator of transcription 3.

Novel engineered probiotic that competes specifically with the pathogen Salmonella for vital nutrients in the inflamed intestine of humans and livestock to prevent or treat infection.

Tumor-targeting oncolytic virus is able to kill cancer cells while sparing normal cells and encodes anti-angiogenic factors that reduced blood vessel formation and may modulate innate immune response.

Identified gene target for treatment of human acute leukemia, brain tumors and melanoma